John Kollins

John A. Kollins was the founder of Satsuma Pharmaceuticals, Inc. since 2016, holding the title of President, Chief Executive Officer & Director.
Current jobs include Chief Executive Officer & Director at Respira Therapeutics, Inc., Director at Symphony ViDA, Inc., Director at Cyrano Therapeutics, Inc. since 2021, and Chief Operating Officer at BioSpace, Inc. (Iowa) since 2012.
Former jobs include Chief Executive Officer & Director at Oncotelic Therapeutics, Inc. from 2008 to 2009, Managing Director at Parnassus Advisors, LLC from 2009 to 2012, Product Manager at Immunex Corp., Chief Business Officer at Athena Neurosciences LLC from 2012 to 2014, Vice President-Business Development at Renovis, Inc. from 2003 to 2004, Chief Business Officer at Elan Pharmaceuticals LLC from 2012 to 2014, Vice President-Business Development at SurroMed, Inc. from 2000 to 2002, Chief Business Officer at CovX Research LLC from 2004 to 2005, and Chief Business Officer & Senior Vice President at Transcept Pharma, Inc. from 2012 to 2014.
Education includes an undergraduate degree from Duke University and an MBA from the University of Virginia Darden School of Business.